We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current IBT market cap is 35.65M. The company's latest EPS is CAD 0.1572 and P/E is 9.16.
Year End 31 July 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 4.31M | 5.21M | 5.31M | 7.89M | 7.49M |
Operating Income | -1.38M | 709k | 856k | 2.27M | 1.48M |
Net Income | -1.27M | 965k | 762k | 1.67M | 3.89M |
Year End 31 July 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 8.39M | 8.59M | 9.46M | 12.95M | 16.83M |
Total Liabilities | 1.81M | 1.47M | 1.56M | 3.2M | 3.22M |
Total Equity | 6.57M | 7.12M | 7.9M | 9.75M | 13.61M |
Year End 31 July 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -453k | 1.37M | 1.21M | 3.58M | 2.25M |
Investing | -53k | 956k | -271k | -145k | -1.01M |
Financing | -54k | -1.2M | -209k | -229k | -334k |
Market Cap | 35.65M |
Price to Earnings Ratio | 9.16 |
Price to Sales Ratio | 4.76 |
Price to Cash Ratio | 4.17 |
Price to Book Ratio | 2.62 |
Dividend Yield | - |
Shares Outstanding | 24.76M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | 25.22% |
52 Week High | 1.45 |
52 Week Low | 1.07 |
Spread (Intraday) | 0.2 (13.79%) |
Company Name | Ibex Technologies Inc |
Address |
suite 100, 5485 par�� street montreal, quebec H4P 1P7 |
Website | https://www.ibex.ca |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions